CRAIF
Latest round
- Series D
Last raised
- Aug 2026
Total raised
- $68M
Investors
- 23
About CRAIF
, a healthcare technology and diagnostics firm that focuses on creating advanced disease detection technologies. The company specializes in non-invasive cancer screening through the analysis of urinary microRNA and its proprietary NANO IP technology. In August 2026, Craif Inc. Craif develops liquid biopsy tests utilizing exosomes, small particles released by cells. These tests analyze biomarkers found in urine to identify disease risks, particularly cancer. Craif's primary product, MySignal, is a cancer risk assessment test designed for early detection and prevention.S. research and development, product launch activities, scale MySignal cancer screening operations, support clinical development and regulatory approval of its pancreatic cancer SaMD program, and accelerate development of its urine-analysis platform for disease detection.
Who invested in CRAIF
23 investors across 8 rounds
See all investors in CRAIF
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Aug 18, 2026
Amount
$30M
Investors
Series C
Jun 11, 2025
Amount
Undisclosed
Investors
Series C
Apr 28, 2025
Amount
$12M
Investors
Series C
Dec 23, 2024
Amount
$6.4M
Investors
Series B
Apr 12, 2022
Amount
$2.6M
Investors
Series B
Nov 2, 2021
Amount
$11M
Investors
Series A
Jun 17, 2020
Amount
$6.1M
Investors
Seed
Feb 13, 2019
Amount
Undisclosed
Investors
Questions about CRAIF
Who invested in CRAIF?
CRAIF has 23 investors on record across 8 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CRAIF raised?
CRAIF has raised 8 venture rounds. Sign up free to see how much each round raised and the total.
When did CRAIF last raise money?
CRAIF's most recent round on record is a Series D, in Aug 2026.
What does CRAIF do?
, a healthcare technology and diagnostics firm that focuses on creating advanced disease detection technologies.
Where is CRAIF headquartered?
CRAIF is headquartered in Tokyo, Japan.
Which VCs invest in companies like CRAIF?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at CRAIF's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like CRAIF? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.